PNU-248686A

N/A

Report date: 2026/03/12 20:00:16

NME

Base Information

Drug NamePNU-248686A

Drug Alias NamePNU-248686A

ClassificationSmall molecules

Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsMatrix metalloproteinase 13 inhibitors

TargetsMatrix metalloproteinase 13Matrix metalloproteinase-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A